Diego Villa, MD, MPH | Authors


Bendamustine/Rituximab as Induction Therapy in MCL

December 09, 2019

Diego Villa, MD, MPH, clinical associate professor, Division of Medical Oncology, The University of British Columbia, discusses a retrospective analysis evaluating bendamustine and rituximab as induction therapy in both transplant eligible and ineligible patients with mantle cell lymphoma.